Bristol-Myers Squibb Loses $6 Billion in Value on Celgene Deal Setback: Brainstorm Health

Sy Mukherjee
0

Happy Monday, readers!

Bristol-Myers Squibb hasn’t exactly had a pristine path to its proposed acquisition of Celgene. Sure, the legacy pharma giant racked up more than 75% of shareholder votes to approve the $74 billion acquisition following a quickly-quashed rebellion from some activist naysayers. But the company hit another hurdle in its Celgene acquisition quest that sent Bristol Myers stock tumbling nearly 7.5%, a $6 billion erasure in market value.

The reason(s)? For one, Bristol-Myers Squibb reported an unfortunate clinical trial result from a late-stage study of its cancer immunotherapy superstar Opdivo in liver cancer. For another—BMS made a somewhat surprising announcement that it would spin off Celgene’s blockbuster psoriasis and arthritis drug Otezla, slated to rake in nearly $2 billion in sales this year alone, in order to address Federal Trade Commission (FTC) antitrust concerns over the M&A.

That means the Bristol-Myers Celgene deal may not close until early 2020, rather than the originally expected timeline by the end of this year.

“Bristol-Myers Squibb reaffirms the significant value creation opportunity of the acquisition of Celgene,” the firm said in a statement. “Together with $2.5 billion of cost synergies, a compelling pipeline and a strong portfolio of marketed products, the company continues to expect growth in sales and earnings through 2025.”

Investors can be a fickle bunch. For now, though, they don’t seem particularly pleased at the decision to lop off one of Celgene’s tried and true cash cows.

Read on for the day’s news.

Sy Mukherjee @the_sy_guy sayak.mukherjee@fortune.com

  • DIGITAL HEALTH

    The digital health funding fever. I explore the record digital health VC funding figures for my latest piece in the Fortune print issue (on news stands, online, and something you’re just generally going to have to click on to get the goods). OK, one spoiler: The venture funding in the field reached an all-time record in 2018. (Fortune)

    UnitedHealth snaps up PatientsLikeMe. Health insurance giant UnitedHealth is already a titan of the medical industry, its grip reaching everything from the pharmacy benefits business to doctors’ networks. It’s now extending into the digital health business via an acquisition of the online PatientsLikeMe portal, according to MobiHealthNews. “This independent unit of UnitedHealth Group invests in research that speeds improvements to drive innovation in healthcare,” said PatientsLikeMe CEO Jamie Heywood in a statement. “We’ve chosen to join with UnitedHealth Group Research & Development because they share that same drive to improve health at the individual level and to ensure that healthcare outcomes across the board are more effective.” (MobiHealthNews)

  • INDICATIONS

    Trump signs health care price transparency executive order. President Donald Trump on Monday signed an executive order aimed at making health care prices more transparent. It’s a pet issue for Health and Human Services Secretary Alex Azar, who claimed that the move would force health care companies to drive down prices once exposed to the light of day. That remains to be seen—public shaming isn’t a proven method for reducing such prices. But at the very least the move should reveal more information on how such pricing works. (The Hill)

  • THE BIG PICTURE

    Supreme Court decides to hear out insurers on Obamacare payments in a surprise. In a surprise decision, the Supreme Court has decided to review lower court rulings that insurance companies aren’t entitled to certain payments under the Affordable Care Act (ACA), aka Obamacare. The so-called “risk corridor” payments were meant to be a safeguard against rising premiums but combated by the Trump administration, which classified them as “bailouts” for insurance companies. (Reuters)

  • REQUIRED READING

    Lessons from the VC Who’s Seen It All Before, by Polina Marinova

    Commentary: The CEO’s Toughest Leadership Challenge—Leading Themselves, by Ron Williams

    Why Microsoft’s Slack Ban May Be a Mistake, by Aaron Pressman

    In Hindsight: How Warby Parker Got Its Start, by Dinah Eng

    Produced by Sy Mukherjee @the_sy_guy sayak.mukherjee@fortune.com Find past coverage. Sign up for other Fortune newsletters.

Advertisement

Recommended Stories

  • Plug Power (PLUG) Reports Q1 Loss, Lags Revenue Estimates

    Plug Power (PLUG) delivered earnings and revenue surprises of -34.38% and 26.18%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

  • Can I Use My RMDs to Transfer Money Into My Roth IRA?

    If you're taking a required minimum distribution from an IRA, 401(k) or other tax-deferred account and don't need the money to cover living expenses, where should you stash that unneeded cash? Investors now need to start taking RMDs at age 73 or, if they were born after 1960, at age 75. Depending on the balances of […] The post Can I Use My RMDs to Transfer Money Into My Roth IRA? appeared first on SmartReads by SmartAsset.

  • Billionaire Bill Gates Has 51% of His Portfolio Invested in 2 Brilliant Stocks

    The Bill and Melinda Gates Foundation Trust outperformed the S&P 500 by a wide margin over the past three years, in part because of these two stocks.

  • ‘Seriously Underwater’ Home Mortgages Tick Up Across the US

    (Bloomberg) -- Roughly one in 37 homes are now considered seriously underwater in the US and that share is much higher across a swath of southern states, according to data out Thursday.Most Read from BloombergMicrosoft’s Xbox Is Planning More Cuts After Studio ClosingsAmericans Are Racking Up ‘Phantom Debt’ That Wall Street Can’t TrackStormy Daniels Will Return to Court in Test of Trump’s DemeanorArm Slides as Tepid Outlook Fuels Concerns Over AI SlowdownNationally, 2.7% of homes carried loan ba

  • Ask an Advisor: Can a Nursing Home Take Our IRA? We Have a $100K IRA and a Trust to Protect Our Assets

    My wife and I are elderly. I have an individual retirement account (IRA) worth about $100,000, and we have a trust set up through our children to protect our assets. If one or both of us have to go into … Continue reading → The post Ask an Advisor: Can a Nursing Home ‘Take Our IRA?' My Wife and I Are Elderly. We Have a $100K IRA and a Trust to Protect Our Assets. appeared first on SmartAsset Blog.

  • Roblox Stock Is Plummeting After Earnings. Here’s What We Know.

    The videogame platform posted a narrower-than-expected quarterly loss and saw sales rise sharply from a year ago.

  • Morgan Stanley Predicts up to 110% Rally for These 2 ‘Strong Buy’ Stocks

    Uncertainty is the word of the day, in reference to the near-term economic future. Sentiment will hinge on the inflation numbers due out next week. March’s figure rose to 3.5%, and April’s job numbers showed a marked slowing in the labor market; that combination has stoked fears of stagflation. But – corporate earnings from Q1 are beating expectations, and the stock market has taken a turn for the better with the S&P 500 closing just below 5,200 yesterday. Economic strategists are still optimist

  • Too many tractors: As boom times fade, farm equipment piles up

    Falling crop prices are leaving agriculture equipment sellers with an excess of unsold tractors and combines. The slower equipment sales are a knock-on effect of corn and soy prices dropping to more than three-year lows as U.S. farm income plummets and equipment makers and dealers are forced to pivot quickly after a period of booming business. Reuters interviewed ten equipment dealers, mostly in the Midwest, as well as farmers and analysts, who said low crop prices combined with persistently high interest rates are deterring farmers from purchasing machinery.

  • Roblox Stock Plunges On Firm's Weak Outlook. Investors Say 'Game Over.'

    Video game platform Roblox beat estimates for the first quarter but guided below views for the current quarter and full year. Roblox stock plummeted on the news.

  • 1 Vanguard ETF That Can Serve as a Complete Stock Portfolio

    This single Vanguard ETF provides a straightforward path to a secure retirement.